SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-180138
Filing Date
2015-05-11
Accepted
2015-05-08 21:41:57
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d908485d10q.htm 10-Q 559595
2 EX-31.1 d908485dex311.htm EX-31.1 6027
3 EX-31.2 d908485dex312.htm EX-31.2 5958
4 EX-32.1 d908485dex321.htm EX-32.1 3830
  Complete submission text file 0001193125-15-180138.txt   4077482

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT alxa-20150331.xml EX-101.INS 474355
6 XBRL TAXONOMY EXTENSION SCHEMA alxa-20150331.xsd EX-101.SCH 40001
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alxa-20150331_cal.xml EX-101.CAL 56983
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alxa-20150331_def.xml EX-101.DEF 115229
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE alxa-20150331_lab.xml EX-101.LAB 320316
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alxa-20150331_pre.xml EX-101.PRE 228405
Mailing Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043 650.944.7000
Alexza Pharmaceuticals Inc. (Filer) CIK: 0001344413 (see all company filings)

IRS No.: 770567768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51820 | Film No.: 15848633
SIC: 2834 Pharmaceutical Preparations